Kai Ding to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Kai Ding has written about Uterine Cervical Neoplasms.
Connection Strength
0.421
-
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol. 2022 07; 166(1):44-49.
Score: 0.164
-
Simple Hysterectomy for Cervical Cancer: Risk Factors for Failed Screening and Deviation From Screening Guidelines. J Low Genit Tract Dis. 2019 Apr; 23(2):124-128.
Score: 0.133
-
Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough. Gynecol Oncol. 2018 04; 149(1):89-92.
Score: 0.124